(Reuters) – Centene Corporation said on Friday it expects to post 2023 adjusted profit between $6.25 per share and $6.40 per share, that would be marginally below analysts’ estimates of $6.34 at midpoint.
The health insurer said it sees total revenue forecast for 2023 between $137.4 billion to $139.4 billion, lower than analysts estimates of $144.48 billion, according to Refinitiv data.
The 2023 medical loss ratio is expected to be in range of 87.2% to 87.8%, Centene said.
Analysts were expecting a medical loss ratio of 87.77%, according to Refinitiv IBES data.
The company, which also said it has authorized a $2 billion increase to its existing stock repurchase program, is expected to give further details about its outlook in its investor day conference later today.
(Reporting by Khushi Mandowara; Editing by Nivedita Bhattacharjee)
